Marshall Urist
Corporate Officer/Principal at ROYALTY PHARMA PLC
Net worth: 77 M $ as of 2024-03-30
Profile
Marshall Urist's current job(s) include Vice President-Research & Investments at RP Management LLC since 2013 and Head-Research & Investments at Royalty Pharma Plc since 2013.
Dr. Urist's former job(s) include Executive Director at Morgan Stanley & Co. LLC from 2011 to 2013 and Research Associate at Merrill Lynch, Pierce, Fenner & Smith, Inc. in 2006.
Dr. Urist's education history includes a doctorate degree from The Trustees of Columbia University in The City of New York in 2005 and an undergraduate degree from The Johns Hopkins University in 1998.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2023-04-10 | 2,335,940 ( 0.97% ) | 71 M $ | 2024-03-30 | |
RPI US Partners 2019 LP
0.06% | 2023-02-16 | 128,594 ( 0.06% ) | 4 M $ | 2024-03-30 |
2023-04-10 | 65,687 ( 0.01% ) | 2 M $ | 2024-03-30 |
Marshall Urist active positions
Companies | Position | Start |
---|---|---|
ROYALTY PHARMA PLC | Corporate Officer/Principal | - |
RP Management LLC
RP Management LLC Miscellaneous Commercial ServicesCommercial Services RP Management LLC provides pharmaceutical royalty liquidity services. It provides liquidity to holders of interests in revenue-producing intellectual property in biopharmaceutical products and finances the clinical development of biopharmaceutical products in exchange for a royalty interest. The firm serves research institutions, inventors, and biotechnology and pharmaceutical companies. The company was founded by Pablo Gerardo Legorreta and Rory B. Riggs in 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | 2013-07-18 |
Former positions of Marshall Urist
Companies | Position | End |
---|---|---|
Morgan Stanley & Co. LLC
Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry. | Analyst-Equity | 2013-06-30 |
Merrill Lynch, Pierce, Fenner & Smith, Inc. /Old/
Merrill Lynch, Pierce, Fenner & Smith, Inc. /Old/ Investment Banks/BrokersFinance Merrill Lynch, Pierce, Fenner & Smith, Inc. (MLPFS) is the SEC-registered broker/dealer subsidiary of Merrill Lynch & Co., Inc., ultimately held by Charlotte-based Bank of America Corp. (NYSE: BAC). The firm was founded in 1958 and is headquartered in New York City. In 2010, Banc of America Securities LLC merged with MLPFS and the firm uses the trade name Bank of America Merrill Lynch. MLPFS's global strategy and economics team serves institutional and individual investors using a wide range of macroeconomic disciplines. Their analysis of global issues provides clients with investment ideas, market forecasts, macro overviews and specific sector recommendations across asset classes, regions and disciplines. Their equity research team conducts fundamental analysis on companies globally and provides institutional and retail clients with industry-specific and in-depth research and analysis on numerous industries. The firm's global fixed-income and equity-linked research focuses on fixed-income and equity derivatives, fixed-income strategy, convertibles, commodities, high-yield, mortgages, municipals and global foreign exchange. | Analyst-Equity | 2006-01-30 |
Training of Marshall Urist
The Trustees of Columbia University in The City of New York | Doctorate Degree |
The Johns Hopkins University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ROYALTY PHARMA PLC | Health Technology |
Private companies | 3 |
---|---|
Merrill Lynch, Pierce, Fenner & Smith, Inc. /Old/
Merrill Lynch, Pierce, Fenner & Smith, Inc. /Old/ Investment Banks/BrokersFinance Merrill Lynch, Pierce, Fenner & Smith, Inc. (MLPFS) is the SEC-registered broker/dealer subsidiary of Merrill Lynch & Co., Inc., ultimately held by Charlotte-based Bank of America Corp. (NYSE: BAC). The firm was founded in 1958 and is headquartered in New York City. In 2010, Banc of America Securities LLC merged with MLPFS and the firm uses the trade name Bank of America Merrill Lynch. MLPFS's global strategy and economics team serves institutional and individual investors using a wide range of macroeconomic disciplines. Their analysis of global issues provides clients with investment ideas, market forecasts, macro overviews and specific sector recommendations across asset classes, regions and disciplines. Their equity research team conducts fundamental analysis on companies globally and provides institutional and retail clients with industry-specific and in-depth research and analysis on numerous industries. The firm's global fixed-income and equity-linked research focuses on fixed-income and equity derivatives, fixed-income strategy, convertibles, commodities, high-yield, mortgages, municipals and global foreign exchange. | Finance |
Morgan Stanley & Co. LLC
Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry. | Finance |
RP Management LLC
RP Management LLC Miscellaneous Commercial ServicesCommercial Services RP Management LLC provides pharmaceutical royalty liquidity services. It provides liquidity to holders of interests in revenue-producing intellectual property in biopharmaceutical products and finances the clinical development of biopharmaceutical products in exchange for a royalty interest. The firm serves research institutions, inventors, and biotechnology and pharmaceutical companies. The company was founded by Pablo Gerardo Legorreta and Rory B. Riggs in 1996 and is headquartered in New York, NY. | Commercial Services |
- Stock Market
- Insiders
- Marshall Urist